Share
Quantitative Drug Safety and Benefit Risk Evaluation (Chapman & Hall
William Wang, Melvin Munsaka, James Buchanan, Judy Li (Author)
·
Crc Pr Inc
· Hardcover
Quantitative Drug Safety and Benefit Risk Evaluation (Chapman & Hall - William Wang, Melvin Munsaka, James Buchanan, Judy Li
£ 121.50
£ 135.00
You save: £ 13.50
Choose the list to add your product or create one New List
✓ Product added successfully to the Wishlist.
Go to My WishlistsIt will be shipped from our warehouse between
Monday, May 27 and
Thursday, May 30.
You will receive it anywhere in United Kingdom between 1 and 3 business days after shipment.
Synopsis "Quantitative Drug Safety and Benefit Risk Evaluation (Chapman & Hall"
Quantitative Methodologies and Process for Safety Monitoring and Ongoing Benefit Risk Evaluation provides a comprehensive coverage on safety monitoring methodologies, covering both global trends and regional initiatives. Pharmacovigilance has traditionally focused on the handling of individual adverse event reports however recently there had been a shift towards aggregate analysis to better understand the scope of product risks.Written to be accessible not only to statisticians but also to safety scientists with a quantitative interest, this book aims to bridge the gap in knowledge between medical and statistical fields creating a truly multi-disciplinary approach that is very much needed for 21st century safety evaluation.
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
- 0% (0)
All books in our catalog are Original.
The book is written in English.
The binding of this edition is Hardcover.
✓ Producto agregado correctamente al carro, Ir a Pagar.
